Oral nicotine consumption does not affect maternal care or early development in mice but results in modest hyperactivity in adolescence.
Nicotine exposure during development can alter behavior in adulthood in mice. One route of nicotine administration that can mimic some of the dynamics of human smoking is administration of the drug to pregnant and nursing mice through the drinking water. It is critical to determine if nicotine administration has an impact on maternal behavior as such changes could lead to persistent behavioral alterations in the offspring, independent of the neuropharmacological effects of the drug. While a number of studies have detected nicotine exposure-induced changes, the effects of nicotine administration through the drinking water on maternal behavior in mice have not been examined comprehensively. In the current study we have compared maternal behaviors of C57BL/6J mice exposed to nicotine in the drinking water to behaviors of animals exposed to saccharin (vehicle) in the drinking water for the first 7days after birth of their litters and find no significant between-group differences in any behaviors measured except passive nursing. We have also assessed the effects of nicotine administration through the drinking water on postnatal weight gain of the pups and find no significant differences between groups. Open-field locomotor activity differences between exposed and unexposed offspring in adolescence were also assessed, with transient hyperactivity detected in nicotine-exposed mice. These data suggest that behavioral differences identified between animals exposed to nicotine through maternal drinking water administration are primarily due to the neuropharmacological effects of the drug and not due to effects of exposure on maternal behavior.
Heath
Christopher J
CJ
Interdepartmental Neuroscience Program, Yale University School of Medicine, New Haven, CT 06508, USA. marina.picciotto@yale.edu
Horst
Nicole K
NK
Picciotto
Marina R
MR
D000284:Administration, Oral; D000704:Analysis of Variance; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D005260:Female; D006948:Hyperkinesis / Q000139:chemically induced*; D008425:Maternal Behavior / Q000187:drug effects*; D051379:Mice; D009043:Motor Activity / Q000187:drug effects; D009538:Nicotine / Q000008:administration & dosage*; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects
D009538:Nicotine
Horm Behav. 2010 Apr;57(4-5):396-404
20096699
Annu Rev Psychol. 2010;61:439-66, C1-3
19958180
J Child Psychol Psychiatry. 2007 Mar-Apr;48(3-4):224-44
17355397
Psychopharmacology (Berl). 1995 Jan;117(1):2-10; discussion 14-20
7724697
Behav Processes. 1986 Jan;12(1):45-50
24924536
Nat Genet. 2001 Mar;27(3):322-6
11242117
Science. 1972 Aug 18;177(4049):619-21
5065617
Neurosci Biobehav Rev. 2001 May;25(3):235-60
11378179
Brain Res Mol Brain Res. 1996 Apr;37(1-2):145-50
8738145
Neurobiol Learn Mem. 2008 Oct;90(3):527-36
18662793
Neuroreport. 2002 May 24;13(7):961-3
12004199
Int J Dev Neurosci. 2004 Aug-Oct;22(5-6):329-37
15380832
Behav Genet. 1970 Aug-Nov;1(3):195-211
5527377
Genes Brain Behav. 2008 Mar;7(2):184-92
17608702
Neuropsychopharmacology. 2007 Mar;32(3):693-9
16554741
Food Chem Toxicol. 2003 Jun;41(6):807-17
12738186
Proc Soc Exp Biol Med. 1974 Oct;147(1):110-3
4474667
Nicotine Tob Res. 2003 Feb;5(1):117-24
12745513
Behav Brain Res. 2004 Apr 2;150(1-2):159-70
15033289
J Endocrinol. 2010 May;205(2):159-70
20190011
Child Dev. 2010 Jan-Feb;81(1):41-79
20331654
J Neurochem. 2003 Mar;84(6):1431-41
12614343
Neurosci Lett. 2008 Jul 11;439(2):187-91
18524488
Brain Res. 2007 Jul 16;1158:28-38
17543293
Reprod Toxicol. 2010 Jun;29(3):378-80
20080174
Neuropharmacology. 2009;56 Suppl 1:254-62
18692078
J Neurosci. 1995 Mar;15(3 Pt 1):1912-39
7891142
Neuropharmacology. 2004;47 Suppl 1:132-9
15464132
Psychopharmacology (Berl). 2006 Mar;184(3-4):328-38
16133126
Life Sci. 2006 Feb 23;78(13):1483-93
16324718